Artificial Intelligence in Drug Discovery

En podkast av Simon Smith

Kategorier:

12 Episoder

  1. Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus

    Publisert: 7.8.2018
  2. Lucas Siow of ProteinQure on AI for Protein-Based Drugs

    Publisert: 7.8.2018
  3. Regina Barzilay, AI Small Molecule Discovery and Synthesis

    Publisert: 30.7.2018
  4. Tim Guilliams and David Brown, Healx, AI for Rare Diseases

    Publisert: 26.7.2018
  5. John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology

    Publisert: 18.7.2018
  6. Kristen Fortney, CEO of BioAge Labs, on AI Aging Research

    Publisert: 10.7.2018
  7. Sam Cooper, CEO of Phenomic AI, on Automated HCS and More

    Publisert: 28.6.2018
  8. Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology

    Publisert: 20.6.2018
  9. Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics

    Publisert: 11.6.2018
  10. Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype

    Publisert: 29.5.2018
  11. Mauro Cozzi, Researchably, AI for Better Biomedical Search

    Publisert: 22.5.2018
  12. Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"

    Publisert: 14.5.2018

1 / 1

Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!

Visit the podcast's native language site